Hanall Biopharma Co., Ltd. (KRX:009420)
South Korea · Delayed Price · Currency is KRW 64,600
+300 (0.47%)
At close: Aug 28, 2026
Hanall Biopharma Market Cap
Hanall Biopharma has a market cap or net worth of 3.28 trillion as of August 28, 2026. Its market cap has increased by 113.01% in one year.
Market Cap
3.28T
Enterprise Value
3.30T
Revenue
162.66B
Ranking
n/a
PE Ratio
n/a
Stock Price
64,600.00
ChartMarket Cap Chart
Since August 30, 1995, Hanall Biopharma's market cap has increased from 26.30B to 3.28T, an increase of 12,376.28%. That is a compound annual growth rate of 16.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 3.28T | 47.69% |
| Dec 30, 2025 | 2.22T | 13.35% |
| Dec 30, 2024 | 1.96T | -12.72% |
| Dec 28, 2023 | 2.25T | 148.89% |
| Dec 29, 2022 | 902.29B | -16.29% |
| Dec 30, 2021 | 1.08T | -43.84% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hanmi Pharm. | 6.73T |
| Yuhan | 6.21T |
| Celltrion Pharm | 1.88T |
| GC Biopharma | 1.49T |
| Daewoong Pharmaceutical | 1.41T |
| Chong Kun Dang Pharmaceutical | 906.51B |
| Boryung | 763.70B |
| Daewoong | 709.58B |